Ad is loading...
BDULF
Price
$0.85
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
RHE
Price
$1.40
Change
+$0.09 (+6.87%)
Updated
Nov 14 closing price
Ad is loading...

BDULF vs RHE

Header iconBDULF vs RHE Comparison
Open Charts BDULF vs RHEBanner chart's image
Bangkok Dusit Medical Services Public
Price$0.85
Change-$0.00 (-0.00%)
Volume$2K
CapitalizationN/A
Regional Health Properties
Price$1.40
Change+$0.09 (+6.87%)
Volume$33.67K
CapitalizationN/A
BDULF vs RHE Comparison Chart
Loading...
View a ticker or compare two or three
VS
BDULF vs. RHE commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDULF is a Hold and RHE is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BDULF: $0.85 vs. RHE: $1.40)
Brand notoriety: BDULF and RHE are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BDULF: 10% vs. RHE: 33%
Market capitalization -- BDULF: $13.33B vs. RHE: $4.71M
BDULF [@Medical/Nursing Services] is valued at $13.33B. RHE’s [@Medical/Nursing Services] market capitalization is $4.71M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $88.21B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $3.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDULF’s FA Score shows that 1 FA rating(s) are green whileRHE’s FA Score has 0 green FA rating(s).

  • BDULF’s FA Score: 1 green, 4 red.
  • RHE’s FA Score: 0 green, 5 red.
According to our system of comparison, BDULF is a better buy in the long-term than RHE.

Price Growth

BDULF (@Medical/Nursing Services) experienced а 0.00% price change this week, while RHE (@Medical/Nursing Services) price change was -23.25% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.60%. For the same industry, the average monthly price growth was -0.82%, and the average quarterly price growth was +1650.84%.

Reported Earning Dates

RHE is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Medical/Nursing Services (-3.60% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
BDULF($13.3B) has a higher market cap than RHE($4.71M). BDULF has higher P/E ratio than RHE: BDULF (36.23) vs RHE (0.13). BDULF YTD gains are higher at: 4.532 vs. RHE (-30.990). BDULF has higher annual earnings (EBITDA): 22.9B vs. RHE (-831K). BDULF has more cash in the bank: 17.8B vs. RHE (1.43M). RHE has less debt than BDULF: RHE (54.3M) vs BDULF (22.2B). BDULF has higher revenues than RHE: BDULF (93B) vs RHE (22.8M).
BDULFRHEBDULF / RHE
Capitalization13.3B4.71M282,498%
EBITDA22.9B-831K-2,755,716%
Gain YTD4.532-30.990-15%
P/E Ratio36.230.1327,029%
Revenue93B22.8M407,895%
Total Cash17.8B1.43M1,247,372%
Total Debt22.2B54.3M40,884%
FUNDAMENTALS RATINGS
BDULF vs RHE: Fundamental Ratings
BDULF
RHE
OUTLOOK RATING
1..100
462
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
37
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
54100
PRICE GROWTH RATING
1..100
4493
P/E GROWTH RATING
1..100
7394
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDULF's Valuation (25) in the null industry is in the same range as RHE (37) in the Real Estate Investment Trusts industry. This means that BDULF’s stock grew similarly to RHE’s over the last 12 months.

BDULF's Profit vs Risk Rating (67) in the null industry is somewhat better than the same rating for RHE (100) in the Real Estate Investment Trusts industry. This means that BDULF’s stock grew somewhat faster than RHE’s over the last 12 months.

BDULF's SMR Rating (54) in the null industry is somewhat better than the same rating for RHE (100) in the Real Estate Investment Trusts industry. This means that BDULF’s stock grew somewhat faster than RHE’s over the last 12 months.

BDULF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for RHE (93) in the Real Estate Investment Trusts industry. This means that BDULF’s stock grew somewhat faster than RHE’s over the last 12 months.

BDULF's P/E Growth Rating (73) in the null industry is in the same range as RHE (94) in the Real Estate Investment Trusts industry. This means that BDULF’s stock grew similarly to RHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFIV242.05-4.81
-1.95%
F5, Inc.
PDCO19.57-0.43
-2.15%
Patterson Companies
MLYS12.17-0.28
-2.25%
Mineralys Therapeutics
COYA6.81-0.43
-5.94%
Coya Therapeutics
RSLS5.17-0.45
-8.01%
ReShape Lifesciences Inc

BDULF and

Correlation & Price change

A.I.dvisor tells us that BDULF and MD have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDULF and MD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDULF
1D Price
Change %
BDULF100%
N/A
MD - BDULF
8%
Poorly correlated
-3.02%
PIII - BDULF
8%
Poorly correlated
-16.21%
NUMIF - BDULF
7%
Poorly correlated
-28.34%
RHE - BDULF
6%
Poorly correlated
+6.87%
INNV - BDULF
5%
Poorly correlated
-3.11%
More